Head and Neck Steering Committee

The NCI Head and Neck Steering Committee (HNSC) was established in 2007. The HNSC is currently composed of the Steering Committee and four task forces. Members of HNSC include committee co-chairs, representatives from the Cooperative Groups, Specialized Programs of Research Excellence (SPOREs), community oncologists, biostatisticians, pathologists, patient advocates, and NCI staff.

Mission Statement

The HNSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in head and neck clinical research by addressing the design and prioritization of phase III trials in head and neck cancer and large phase II studies.

Roster of Head and Neck Steering Committee (HNSC) members
Arlene Forastiere, M.D., David Schuller, M.D. and Andy Trotti, M.D., Co-chairs

Task Forces

• Metastatic/Recurrent Disease: David Pfister, M.D. and Theodoros Teknos, M.D., Co-chairs
• Previously-untreated Locally Advanced Disease: David Adelstein, M.D. and Drew Ridge, M.D., Ph.D., Co-chairs
• Rare Tumors: Barbara Conley, M.D.and David Eisele, M.D., Co-chairs
• Tumor Biology and Imaging: Thomas E. Carey, Ph.D. and John Waldron, M.Sc., M.D. Co-chairs

Clinical Trials Planning Meetings

• Head and Neck Squamous Cell Cancer and the Human Papillomavirus (Nov. 9-10, 2008)

CCCT Contact: Jean M. Lynn, RN, M.P.H., OCN ®